The impairment of insulin signaling in Alzheimer's disease
- 6 November 2012
- journal article
- review article
- Published by Wiley in IUBMB Life
- Vol. 64 (12) , 951-957
Abstract
Alterations of the insulin signaling cascade underlie cognitive decline and the development of several neurodegenerative diseases. In recent years, a great interest has been put in studying the interaction between diabetes and Alzheimer's disease (AD). In fact, evidence shows that both diseases present several biochemical similarities including defects in the insulin signaling pathway. Here, we give an overview of the main functions of insulin in the central nervous system. The impact of insulin signaling impairment in brain aging and AD is also discussed. Finally, we present evidence supporting the notion that insulin is a link between diabetes and AD. © 2012 IUBMB IUBMB Life, 64(12): 951–957, 2012Keywords
This publication has 51 references indexed in Scilit:
- Alzheimer's Disease and Diabetes: An Integrative View of the Role of Mitochondria, Oxidative Stress, and InsulinJournal of Alzheimer’s Disease, 2012
- 2012 Alzheimer's disease facts and figures Alzheimer's Association ∗Alzheimer's & Dementia, 2012
- Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelationBrain Research, 2012
- Insulin in Central Nervous System: More than Just a Peripheral HormoneJournal of Aging Research, 2012
- Alzheimer's diseaseNature, 2011
- Brain fuel metabolism, aging, and Alzheimer’s diseaseNutrition, 2011
- An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's DiseaseJournal of Alzheimer’s Disease, 2009
- A decade of modeling Alzheimer's disease in transgenic miceTrends in Genetics, 2006
- Alzheimer's DiseaseNew England Journal of Medicine, 2004
- Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-proteinJournal of Alzheimer’s Disease, 2001